Full Press Release Details
dupixent dupilumab fda approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis eoe.
REGN
dupixent dupilumab fda approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis eoe
Key Takeaway: dupixent dupilumab fda approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis eoe